ImmuneID
Boston
About ImmuneID
ImmuneID is a precision immunology company using its proprietary platform to simultaneously identify and therapeutically target millions of antibody interactions that drive immune diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $67.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2021)
- Website: immuneidrx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/immuneid-94292 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.